Stocktoria
Cardlytics, Inc. CDLX
Cardlytics, Inc. (CDLX) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $233.3M at a -44.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.206 |
| Retained earnings / assets | -4.915 |
| EBIT / assets | -0.356 |
| Equity / liabilities | -0.022 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CDLX | Cardlytics, Inc. | 5/9 | -17.09 | — | -16.2% |
| NXDR | Nextdoor Holdings, Inc. | 4/9 | 6.62 | — | +4.2% |
| SMWB | SIMILARWEB LTD. | 4/9 | -6.63 | — | +13.1% |
| PUBM | PubMatic, Inc. | 5/9 | 2.55 | — | -2.9% |
| HSTM | HEALTHSTREAM INC | 5/9 | 3.21 | 42.6 | +4.3% |
| HCAT | Health Catalyst, Inc. | 5/9 | -8.96 | — | +1.5% |
| LGCL | Lucas GC Ltd | 5/9 | 4.64 | — | +2.3% |
About Cardlytics, Inc.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. Cardlytics, Inc. was incorporated in 2008 and is headquartered in Atlanta, Georgia.
FAQ
Is CDLX financially healthy?
Cardlytics, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does CDLX pay a dividend?
No, Cardlytics, Inc. does not currently pay a dividend.
How profitable is CDLX?
In FY2025, Cardlytics, Inc. had a net margin of -44.4%.
What is the analyst price target for CDLX?
The average Wall-Street price target for Cardlytics, Inc. is $10.75, about 156.0% above the recent price, from 4 analysts (consensus: hold).
Is CDLX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Cardlytics, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.